Role of κ-opioid receptor activation in pharmacological preconditioning of swine

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Coles Jr , James A ^a,b   Sigg, Daniel C ^a,b   Iaizzo, Paul A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Morphine; Norbinaltorphimine; Pentazocine

Indexed keywords

ENKEPHALIN; KAPPA OPIATE RECEPTOR; MORPHINE; NORBINALTORPHIMINE; PENTAZOCINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROARRHYTHMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL;

EID: 0038781998     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00843.2002     Document Type: Article

References (55)

1. Aitchison KA, Baxter GF, Awan MM, Smith RM, Yellon DM, and Opie LH. Opposing effects on infarction of δ- and κ-opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol 95: 1-11, 2000.
2. Bell SP, Sack MN, Patel A, Opie LH, and Yellon DM. δ-Opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 36: 2296-2302, 2000.
3. Bergey JL and Beil ME. Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pigs. Eur J Pharmacol 90: 427-431, 1983.
4. Bergey JL, Nocella K, and McCallum JD. Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine. Eur J Pharmacol 81: 205-216, 1982.
5. Birch PJ, Hayes AG, Sheehan MJ, and Tyers MB. Norbinaltorphimine: antagonist profile at κ-opioid receptors. Eur J Pharmacol 144: 405-408, 1987.
6. Bolling SF, Badhwar V, Schwartz CF, Oeltgen PR, Kilgore K, and Su TP. Opioids confer myocardial tolerance to ischemia: interaction of δ-opioid agonists and antagonists. J Thorac Cardiovasc Surg 122: 476-481, 2001.
7. 5]-enkephalin). J Thorac Cardiovasc Surg 107: 964-967, 1994.
8. Cohen MV, Yang XM, and Downey JM. Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart. Am J Physiol Heart Circ Physiol 277: H1754-H1761, 1999.
9. Curtis MJ and Walker MJ. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 22: 656-665, 1988.
10. Ela C, Barg J, Vogel Z, Hasin Y, and Eilam Y. Distinct components of morphine effects on cardiac myocytes are mediated by the κ- and δ-opioid receptors. J Mol Cell Cardiol 29: 711-720, 1997.
11. Fryer RM, Hsu AK, Nagase H, and Gross GJ. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial vs. sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther 294: 451-457, 2000.
12. Fryer RM, Patel HH, Hsu AK, and Gross GJ. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol 281: H1184-H1192, 2001.
13. Fryer RM, Pratt PF, Hsu AK, and Gross GJ. Differential activation of extracellular signal-regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 296: 642-649, 2001.
14. Fryer RM, Wang Y, Hsu AK, and Gross GJ. Essential activation of PKC-δ in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280: H1346-H1353, 2001.
15. Grund F, Sommerschild HT, Kirkeboen KA, and Ilebekk A. Proarrhythmic effects of ischemic preconditioning in anesthetized pigs. Basic Res Cardiol 92: 417-425, 1997.
16. Janse MJ and Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69: 1049-1169, 1989.
17. Lawson CS, Coltart DJ, and Hearse DJ. "Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol 25: 1391-1402, 1993.
18. ATP channels. Circ Res 84: 1396-1400, 1999.
19. Liu Y, Ytrehus K, and Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668, 1994.
20. Markiewicz W, Finberg JP, and Lichtig C. Morphine increases myocardial infarction size in rats. Anesth Analg 61: 843-846, 1982.
21. Martin WR. Pharmacology of opioids. Pharmacol Rev 35: 283-323, 1983.
22. ATP channels in myocytes. Circulation 103: 290-295, 2001.
23. Miki T, Cohen MV, and Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 186: 3-12, 1998.
24. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
25. Ovize M, Aupetit JF, Rioufol G, Loufoua J, Andre-Fouet X, Minaire Y, and Faucon G. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart. Am J Physiol Heart Circ Physiol 269: H72-H79, 1995.
26. Ovize M, Przyklenk K, Hale SL, and Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation 85: 2247-2254, 1992.
27. ATP channel opening. FASEB J 16: 1468-1470, 2002.
28. Paterson SJ, Robson LE, and Kosterlitz HW. Classification of opioid receptors. Br Med Bull 39: 31-36, 1983.
29. Portoghese PS, Lipkowski AW, and Takemori AE. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci 40: 1287-1292, 1987.
30. Pugsley MK. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 93: 51-75, 2002.
31. Pugsley MK, Penz WP, Walker MJ, and Wong TM. Antiarrhythmic effects of U-50488H in rats subjected to coronary artery occlusion. Eur J Pharmacol 212: 15-19, 1992.
32. Pugsley MK, Penz WP, Walker MJ, and Wong TM. Cardiovascular actions of the κ-agonist, U-50488H, in the absence and presence of opioid receptor blockade. Br J Pharmacol 105: 521-526, 1992.
33. Pugsley MK, Yu EJ, and Goldin AL. U-50488H, a κ-opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine. Proc West Pharmacol Soc 43: 47-50, 2000.
34. Qiu Y, Tang XL, Park SW, Sun JZ, Kalya A, and Bolli R. The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-min coronary occlusion. Circ Res 80: 730-742, 1997.
35. Schott RJ, Rohmann S, Braun ER, and Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66: 1133-1142, 1990.
36. 1- but not μ- or κ-opioid receptors. Circulation 97: 1282-1289, 1998.
37. Schultz JE, Hsu AK, and Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78: 1100-1104, 1996.
38. Schultz JE, Rose E, Yao Z, and Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol Heart Circ Physiol 268: H2157-H2161, 1995.
39. ATP channels. Am J Physiol Heart Circ Physiol 274: H909-H914, 1998.
40. Schulz R, Gres P, and Heusch G. Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs. Am J Physiol Heart Circ Physiol 280: H2175-H2181, 2001.
41. Sigg DC, Coles JA, Gallagher WJ, Oeltgen PR, and Iaizzo PA. Opioid preconditioning: myocardial function and energy metabolism. Ann Thorac Surg 72: 1576-1582, 2001.
42. Sigg DC, Coles JA Jr, Oeltgen PR, and Iaizzo PA. Role of 8-opioid receptor agonists on infarct size reduction in swine. Am J Physiol Heart Circ Physiol 282: H1953-H1960, 2002.
43. Smith WT 4th, Fleet WF, Johnson TA, Engle CL, and Cascio WE. The Ib phase of ventricular arrhythmias in ischemic in situ porcine heart is related to changes in cell-to-cell electrical coupling. Circulation 92: 3051-3060, 1995.
44. Speechly-Dick ME, Mocanu MM, and Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 75: 586-590, 1994.
45. Vahlhaus C, Schulz R, Post H, Rose J, and Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol 30: 197-209, 1998.
46. Verdouw PD, van den Doel MA, de Zeeuw S, and Duncker DJ. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res 39: 121-135, 1998.
47. Walter B, Bauer R, Gaser E, and Zwiener U. Validation of the multiple colored microsphere technique for regional blood flow measurements in newborn piglets. Basic Res Cardiol 92: 191-200, 1997.
48. Wang GY, Wu S, Pei JM, Yu XC, and Wong TM. κ- but not δ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 280: H384-H391, 2001.
49. Wong TM, Lee AY, and Tai KK. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart - an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 22: 1167-1175, 1990.
50. Xia Q, Zhang WM, Shen YL, and Wong TM. Decreased affinity of κ-receptor binding during reperfusion following ischaemic preconditioning in the rat heart. Life Sci 58: 1307-1313, 1996.
51. Xiao RP, Pepe S, Spurgeon HA, Capogrossi MC, and Lakatta EG. Opioid peptide receptor stimulation reverses β-adrenergic effects in rat heart cells. Am J Physiol Heart Circ Physiol 272: H797-H805, 1997.
52. Ytrehus K, Liu Y, and Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol Heart Circ Physiol 266: H1145-H1152, 1994.
53. Yu X, Zhang W, Bian J, and Wong TM. Pro- and anti-arrhythmic effects of a κ-opioid receptor agonist: a model for the biphasic action of a local hormone in the heart. Clin Exp Pharmacol Physiol 26: 842-844, 1999.
54. Yu XC, Wang HX, Pei JM, and Wong TM. Anti-arrhythmic effect of κ-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 31: 1809-1819, 1999.
55. Zhang WM, Jin WQ, and Wong TM. Multiplicity of κ-opioid receptor binding in the rat cardiac sarcolemma. J Mol Cell Cardiol 28: 1547-1554, 1996.